RAYSA REDONDO: Open Payments
NPI 1477034346 · OAKLAND PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,682 in 129 payments from 13 companies in 2025. Trend: 2023 $158 · 2024 $464 · 2025 $2,682
Food & beverage: $2,581Education: $101
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $505 |
| Neurocrine BioSciences, Inc. | 20 | $466 |
| Janssen Pharmaceuticals, Inc | 25 | $465 |
| Otsuka America Pharmaceutical, Inc. | 20 | $380 |
| Teva Pharmaceuticals USA, Inc. | 15 | $295 |
| Alkermes, Inc. | 14 | $242 |
| ABBVIE INC. | 3 | $84 |
| Axsome Therapeutics, Inc. | 4 | $80 |
| Lundbeck LLC | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
Products named: CAPLYTA, INGREZZA, INVEGA SUSTENNA, ARISTADA, ABILIFY ASIMTUFII, REXULTI, AUSTEDO XR, ABILIFY MAINTENA.
Industry payments across FL — which companies pay providers there.
